CXCR4 and neoplasm: Furthermore, by performing the in vivo experiments, we evidenced that knock-down of CXCR4 enhanced the suppressing effects of cisplatin on tumor weight (Figure 5(a,b)) and volume (Figure 5(c)) in tumor-bearing mice models established by using the SW839 cells.